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Catestatin is a cationic and hydrophobic peptide derived from the enzymatic cleavage of the prohormoneChromograninA. Initially
identified as a potent endogenous nicotinic–cholinergic antagonist, Catestatin has recently been shown to act as a novel regulator
of cardiac function and blood pressure and as a cardioprotective agent in both pre- and postconditioning through AKT-dependent
mechanisms. The aim of this study is to investigate the potential role of Catestatin also on cardiac metabolism modulation,
particularly on cardiomyocytes glucose uptake. Experiments were performed on isolated adult rat cardiomyocytes. Glucose uptake
was assessed by fluorescent glucose incubation and confocal microscope analysis. Glut4 plasma membrane translocation was
studied by immunofluorescence experiments and evaluation of the ratio peripheral vs internal Glut4 staining. Furthermore, we
performed immunoblot experiments to investigate the involvement of the intracellular pathway AKT/AS160 in the Catestatin
dependent Glut4 trafficking. Our results show that 10 nMCatestatin induces a significant increase in the fluorescent glucose uptake,
comparable to that exerted by 100 nM Insulin. Moreover, Catestatin stimulates Glut4 translocation to plasma membrane and both
AKT and AS160 phosphorylation. All these effects were inhibited by Wortmannin. On the whole, we show for the first time that
Catestatin is able to modulate cardiac glucose metabolism, by inducing an increase in glucose uptake through Glut4 translocation
to the plasma membrane and that this mechanism is mediated by the AKT/AS160 intracellular pathway.
1. Introduction
In the last decade, the 21-aa endogenous peptide Cates-
tatin (Cts) has emerged as a multiple regulator of several
physiological processes, including catecholamine release,
baroreceptor activation, sympathetic nervous system activity,
fat metabolism, antimicrobial activity, human neutrophil,
monocyte, and mast cell migration and myocardial func-
tion [1]. In particular respect to the cardiovascular sys-
tem Cts exerts cardiosuppressive effects both centrally and
peripherally. Central effects are elicited by the improvement
of baroreflex sensitivity and heart rate variability [2–4].
Peripheral effects consist in the decrease of blood pressure
(stimulating histamine release [5] and evoking vasodilation
[6]) and in the inhibition of catecholamine secretion [7].
Moreover, as Chromogranin A (CgA) is directly produced
in the myocardium itself and processed to Cts [8, 9], Cts
can exert direct influence on myocardial function. In partic-
ular in Langendorff-perfused rat heart Cts induces negative
inotropic and lusitropic effects under basal and stimulated
conditions (isoproterenol and endothelin), through ß2-AR-
Gi/o-NO-cGMP dependent pathway [10]. In rat papillary
muscles and isolated cardiomyocytes Cts exerts an antiadren-
ergic effect through a PI3K-AKT-eNOS mechanism [11]. On
the whole these results suggest that Cts can protect the heart
against sympathetic overstimulation.
Catestatin was also tested for its potential cardiopro-
tective activity respect to ischemia/reperfusion damage.
In isolated rat heart, Cts reduced the postischemic rise
of diastolic LVP and improved postischemic recovery of
developed LVP [12], through PI3K/AKT and PKC path-
way [13]. In addition, in isolated adult rat cardiomyocytes
subjected to simulated ischemia/reperfusion protocol, Cts
induced an increase in cell survival with a mechanism
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mediated by AKT-GSK3ß-PLB-eNOS, converging on the
preservation of mithocondrial membrane potential [14].
Moreoever, Cts showed also preconditioning effect, reducing
the cardiac ischemia/reperfusion injury via binding to the
cholinergic muscarinic type 2 receptor and via activation
of the ERK1/2 and PI3K/AKT pathway, thus inhibiting the
endoplasmatic reticulum stress-induced cellular apoptosis
[15].
Based on these previous studies we pointed our attention
on heart metabolism as a further potential target of this
peptide, and in particular we focused on the improvement of
glucose uptake, which represents a basic target for cardiopro-
tective strategies. Cardiac glucose uptake can be impaired in
several pathological conditions, due as an example to failure
in insulin stimulation of Glut4; therefore the presence of
an alternative pathway might be developed into a protective
strategy.
2. Materials and Methods
2.1. Animal Care and Sacrifice. Experiments were performed
on rats which were allowed ad libitum access to tap water
and standard rodent diet. The animals received human care
in compliance with the Guide for the Care and Use of
Laboratory Animals published by the US National Institutes
of Health (NIH Publication No. 85-23, revised 1996) and
in accordance with Italian law (DL-116, Jan. 27, 1992). The
scientific project was supervised and approved by the Italian
Ministry of Health, Rome, and by the ethical committee of
the University of Torino. Young adult rats were anaesthetized
by i.p. injection of Pentobarbital (Nembutal, 100 mg/Kg) and
killed by stunning and cervical dislocation.
2.2. Solutions andDrugs. Tyrode standard solution contained
(mM): 154 NaCl, 4 KCl, 2 CaCl
2
, 1 MgCl
2
, 5.5 D-glucose, 5
HEPES, and pH adjusted to 7.34 with NaOH.
All chemicals were purchased from Sigma Aldrich unless
otherwise specified.
2.3. Adult Rat Ventricular Cells Isolation. Isolated ventricular
cells were obtained from adult rat hearts by enzymatic dis-
sociation as described previously [11]. Briefly, after sacrifice,
the rat hearts were explanted, washed in modified Ca2+-
free Tyrode solution, and cannulated via the aorta. All the
following operations were carried on under a laminar flow
hood. The heart was perfused at a constant flow rate of 10
ml/min with Ca2+-free Tyrode solution with a peristaltic
pump for approximately 5min (37∘C) to wash away the blood
and then with 10 ml of Ca2+-free Tyrode supplemented with
collagenase (0.3 mg/ml) and protease (0.02 mg/ml). Hearts
were then perfused and enzymatically dissociated with 30
ml of Ca2+-free Tyrode containing 50 𝜇M CaCl
2
and the
same enzymatic concentration mentioned before. Atria and
ventricles were then separated and the ventricles were cut in
small pieces and shaken for 10 minutes in 20 ml of Ca2+-free
Tyrode solution in presence of 50 𝜇MCaCl
2
, collagenase and
protease.
2.4. Glucose Uptake Measurements. Cardiomyocytes plated
on laminin-treated glass bottom dishes (MatTek Corpora-
tion) in Tyrode solution were stimulated for 15 minutes
with 100 nM Insulin (Ins), 10 nM Cts (Phoenix Pharma-
ceuticals), or 10 nM Cts + 100 nM Wortmannin (Wm) and
then loaded with 300 𝜇M 2-(7-Nitrobenz-2-oxa—1,3-diazol-
4-yl)Amino)-2-Deoxyglucose) (2-NBDG, Life Technologies)
for 20 minutes in the dark. 2-NBDG loading was performed
in glucose-free Tyrode solution. After 1 wash in Tyrode
standard solution cells were observed in confocalmicroscopy.
2.5. Immunofluorescence and Confocal Microscopy. Isolated
cardiomyocytes plated on cover slide in Tyrode solution were
stimulated for 15 minutes with 100 nM Ins, 10 nM Cts, or 10
nM Cts + 100 nM Wm. Cells were fixed for 30 minutes in
4% paraformaldehyde in 0.1 M phosphate buffer (PB), pH 7.3.
After three washes with PBS, cells were incubated 20 minutes
with 0.3% Triton and 1% bovine serum albumin (BSA) in PBS
and stained with the primary antibodies 24h at 4∘C. Cover
slides were washed twice with PBS and incubated 1h at room
temperature with the secondary antibody. After two washes
in PBS cover slides were mounted on standard slides with
DABCO and observed after 24h under confocal microscope.
Weused a polyclonal anti-Glut4 antibody (ThermoFisher Sci-
entific, 1:100) and an Alexa Fluor 568 anti-rabbit (Molecular
Probes, 1:1000).
Confocal fluorimetric measurements were performed
using an Olympus Fluoview 200 laser scanning confocal
system (Olympus America Inc., Melville, NY, USA) mounted
on an inverted IX70 Olympus microscope, equipped with
a 60X Uplan FI (NA 1.25) oil-immersion objectives. Image
processing and analysis were performedwith ImageJ software
(Rasband, W.S., U. S. National Institutes of Health, Bethesda,
MA, http:// rsb.info.nih.gov/ij/, 1997–2008).
2.6. Glut4 Translocation Analysis. Glut4 staining measure-
ments of both cell periphery and cell interior were performed
with the ABSnake plugin of the ImageJ Software. Briefly, for
each cardiomyocyte the ABSnake plugin was employed to
design a ROI (region of interest) band of 12 𝜇m around the
plasmamembrane and the fluorescence intensities of both the
band and the cellular inside were evaluated.
2.7.Western Blot. Cardiomyocytes in suspensionwere stimu-
lated for 15 minutes with 100 nM Ins, 10 nM Cts or 10 nM Cts
+ 100 nM Wm in Tyrode solution containing 50 𝜇M Ca2+,
with gentle agitation. Proteins were extracted with Pierce
RIPA buffer (Thermo Scientific) plus inhibitors cocktail.
Proteins (50 𝜇g per lane) were resolved by 8% SDS–PAGE,
transferred to a polyvinylidene fluoride membrane (PVDF,
Millipore) in cold transfer buffer (25 mM Tris pH 8.3, 192
mM glycine, 0.1% SDS, and 20% methanol), and blocked
overnight in TBST (10 mM Tris-HCl pH 7.5, 0.1 M NaCl,
and 0.1% Tween 20) plus 5% BSA. PVDF membranes were
incubated overnight at +4∘C with primary antibody (AKT,
1:1000 dilution, Cell Signalling Technology; pAKT, 1:1000
dilution, Cell Signalling Technology; pAS160, 1:1000 dilution,
Thermo Scientific; 𝛼-sarcomeric actin, 1:5000 dilution) in 1%
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Figure 1: Cts stimulates glucose uptake. (a) Representative confocal images of adult rat cardiomyocytes incubated with the fluorescent
glucose analog 2-NBDG in control, 100 nM Ins, 10 nM Cts, 10 nM Cts + 100 nM Wm. Pseudocolor images better show the fluorescence
intensity variation. (b) Bar graph summarizing the experiments of fluorescent glucose uptake.Themean fluorescence intensity was 101.74±13.8
in control (n=72), 300.23±42.73 for Ins (n=30), 346.00±40.30 for Catestatin (n=52), and 137.12±19.63 for Cts+Wm (n=25). ∗∗∗p <0.001.
BSA TBST, washed again and then incubated for 1h with
the suitable horseradish peroxidase-conjugated secondary
antibody (1:1500 goat a-rabbit, 1:10000 goat a-mouse,Thermo
Scientific), followed by a second set of three washes in TBST.
Bands were visualized with Western Lightning Plus ECL
(Perkin Elmer). Protein levels were determined using ImageJ
software and normalized corresponding to AKT level for
pAKT and to 𝛼-actin level for pAS160 protein. Aspecific
staining by secondary antibodies was checked.
2.8. Statistics. Data were expressed as mean ± standard
errors. For differences between several mean values one-
way ANOVA was performed. Differences with p<0.05 were
regarded as statistically significant.
3. Results
3.1. Catestatin Increases Fluorescent Glucose Uptake. In order
to investigate the potential role of Cts on glucose uptake,
we performed measurements in confocal microscopy of the
fluorescent glucose analog 2-NBDG absorption in adult rat
cardiomyocytes. Cardiomyocytes were incubated with 300
𝜇M 2-NBDG for 20 minutes in the dark after 15 minutes
stimulation with 10 nM Cts, 100 nM Ins (positive control), or
10 nMCts + 100 nMWm.Our results (Figure 1, panels (a) and
(b)) showed a significant increase in intracellular fluorescence
in Cts treated cells respect to control cells. The effect of Cts
was comparable to that obtained with Ins andwas reverted by
Wm(Figure 1).The bar graph in Figure 1, panel (b), represents
the mean fluorescence intensity in the different experimental
conditions.
3.2. Catestatin Induces Glut4 Translocation from the Cytosol
to the PlasmaMembrane. To verify the involvement of Glut4
in the Cts dependent modulation of glucose absorption we
performed immunofluorescence experiments using a Glut4
antibody, followed by a detailed image analysis of peripheral
vs internal fluorescence staining, in the same experimental
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Figure 2: Cts induces Glut4 translocation to the plasma membrane. (a) Typical confocal images of Glut4 staining. Pseudocolor images
better show the fluorescence intensity variation. (b) Bar graph summarizing the immunofluorescence experiments analysis. The peripheral
vs internal Glut4 staining was 0.86±0.04 in control (n=21), 1.045±0.045 for Ins (n=18), 1.23±0.08 for Cts (n=16), and 0.84±0.02 for Cts+Wm
(n=29). ∗p <0.05, ∗∗∗p <0.001.
conditions described in Section 3.1. The results of these
experiments are showed in Figure 2, panels (a) and (b):
in control conditions Glut4 staining appears confined in
the intracellular space, while after Cts and Ins stimulation
the fluorescent signal is clearly localized to the peripheral
plasmalemma, thus suggesting theGlut4 translocation. Treat-
ment with Wm abolishes the effect of Cts.
3.3. Catestatin Stimulates AKT and AS160 Phosphorylation.
As several studies demonstrated that AKT phosphorylation
mediates multiple effects of Cts [4], we hypothesized that also
the Cts-dependent glucose uptake was promoted byAKT and
consequently by its target AS160. To verify this hypothesis
we performed western blot experiments for AKT(Ser473)
and AS160(Thr642) phosphorylation. As shown in Figures 3
and 4, Cts, similarly to Ins, stimulates both AKT and AS160
phosphorylation while Wm reverted this effect.
4. Discussion
In physiological conditions cardiomyocytes metabolism
mainly takes place through fatty acids (70% of ATP pro-
duction) and to a lesser extent (20% of ATP production)
through glucose oxidation [16]. Significantly, the substrate
preference of the heart switches throughout the life cycle as
well as under physiological and pathological conditions. In
particular, in response to ischemia or hypertrophy, mainly in
the first phase of the diseases, the heart shifts towards glucose
metabolism. This change ameliorates myocardial contractile
efficiency by improving the stoichiometric ratio of ATP
production to oxygen consumption and minimizes oxidative
BioMed Research International 5
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Figure 3: Cts stimulates AKT phosphorylation. Representative western blot experiment and summarizing bar graph showing AKT
phosphorylation after Cts stimulation. Ins is the positive control. Wm reverted the effect of Cts; n= 4. Percentage values were as follows:
Contr 100%, Ins 235.7±50.1%, Cts 163.8±24.2%, and Cts+Wm 79.9±16.8%. ∗p <0.05.
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Figure 4: Cts stimulates AS160 phosphorylation. Representative western blot experiment and summarizing bar graph of AS160
phosphorylation induced by Cts. Ins is the positive control. Wm reverted the effect of Cts; n= 6. Percentage values were as follows: Contr
46.4±6.7%, Ins 85.9±8.5%, Cts 71.1±11.4%, and Cts+Wm 36.3±7.9%. ∗p <0.05.
losses through mitochondrial respiratory chain uncoupling
associated with fatty acid metabolism. On the contrary, the
diabetic heart shows impaired glucose uptake and reduced
glucose oxidation, associated with a shift towards fatty acid
oxidation, intracellular storage of lipids, and cell death
through apoptosis and autophagy [16, 17].
Grounded on these remarks, the search for agonists able
to potentiate glucose metabolism and uptake could represent
an important strategy to preserve heart function in disease
conditions.
In this perspective we focused our attention on the
vasoactive peptide Cts, extensively studied as a regulator of
cardiac function and blood pressure and as a cardioprotective
agent in both pre- and postconditioning through AKT-
dependent mechanisms [4]. In particular, we hypothesized
that in adult rat cardiomyocytes Cts could increase the
first step in cardiac glucose metabolism and glucose uptake
mediated by the Glut4 transporters, by inducing Glut4
translocation to the plasma membrane. We used 10 nM
Catestatin, a mildly high concentration with respect to the
plasmatic level measured in healthy subject [18].
As shown in Figures 1 and 2, Cts significantly enhanced
both glucose uptake and Glut4 translocation.
Interestingly, these effects of Cts were inhibited by
the PI3K inhibitor Wortmannin. Previously, we showed
that Cts, both on endothelial cells and cardiomyocytes,
activates the PI3K-AKT signaling, exerting indirect antia-
drenergic and direct cardioprotective effects [11, 14]. The
present results confirm the obligatory role of this pathway
also in the modulation of glucose uptake. As it has been
amply studied, the PI3K-AKT is also the main intracel-
lular pathway used by insulin to induce glucose uptake
[19].
Finally, we showed that Cts induces both AKT and AS160
phosphorylation (Figures 3 and 4). AS160 is a Rab GTP-
ase activating protein that upon phosphorylation by AKT2
dissociates from Glut4 containing vesicles allowing Glut4
insertion in the plasma membrane. This mechanism in the
heart has been also highlighted for Insulin, Neuregulin 1ß,
Nefastin-1, and selective ß2-adrenergic receptor activation
[19–22]. As shown in Figure 2, Cts stimulates both AKT
and AS160 phosphorylation, suggesting that AKT and its
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substrate AS160 were responsible for the insertion of Glut4
in the plasma membrane.
5. Conclusions
In conclusion, we demonstrate for the first time a direct
metabolic role of the vasoactive peptide Cts on cardiomy-
ocytes, adding a new and important piece in the com-
plex puzzle of its cardiovascular functions. Considering the
paramount goals to improve heart metabolism in ischemia
and hypertrophy and to point out agonists having an insulin-
like effect in the diabetic heart, this study acquires remarkable
value in the cardiovascular research field.
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